Conducting research in a pandemic: The power of social media.

Introduction The COVID-19 pandemic has disrupted the way that clinical care is delivered and research is conducted. Clinical encounters have been postponed or transitioned to telehealth, research laboratories throughout the world have shut down, and many clinical research studies have been suspended. At the same time, there has never been such an urgent need to understand, prevent, and find effective treatments for a disease. At the time of this writing, SARS-CoV-2, the virus that causes COVID-19, has infected more than seven million people around the world and caused the deaths of almost half a million people, less than six months after it was first identified (1).

[1]  S. Ng,et al.  Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry , 2020, Gastroenterology.

[2]  J. Yazdany,et al.  Capturing Patient‐Reported Outcomes During the COVID‐19 Pandemic: Development of the COVID‐19 Global Rheumatology Alliance Patient Experience Survey , 2020, Arthritis care & research.

[3]  M. Konig,et al.  Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19 , 2020, Annals of the Rheumatic Diseases.

[4]  J. Yazdany,et al.  The Rheumatology Community responds to the COVID-19 pandemic: the establishment of the COVID-19 global rheumatology alliance , 2020, Rheumatology.

[5]  L. Trupin,et al.  Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry , 2020, Annals of the Rheumatic Diseases.

[6]  M. Gianfrancesco,et al.  Rheumatic disease and COVID-19: initial data from the COVID-19 Global Rheumatology Alliance provider registries , 2020, The Lancet Rheumatology.

[7]  M. Konig,et al.  Festina lente: hydroxychloroquine, COVID-19 and the role of the rheumatologist , 2020, Annals of the Rheumatic Diseases.

[8]  Jinoos Yazdany,et al.  The COVID-19 Global Rheumatology Alliance: collecting data in a pandemic , 2020, Nature Reviews Rheumatology.

[9]  J. Yazdany,et al.  Use of Hydroxychloroquine and Chloroquine During the COVID-19 Pandemic: What Every Clinician Should Know , 2020, Annals of Internal Medicine.

[10]  R. Grainger,et al.  A Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19 , 2020, Annals of Internal Medicine.

[11]  Paul A. Harris,et al.  The REDCap consortium: Building an international community of software platform partners , 2019, J. Biomed. Informatics.

[12]  C. Collins,et al.  AB1385 #rheumjc: 3 year analysis of a twitter based rheumatology journal club , 2018, Education.

[13]  F. Berenbaum,et al.  Social media use among young rheumatologists and basic scientists: results of an international survey by the Emerging EULAR Network (EMEUNET) , 2016, Annals of the rheumatic diseases.

[14]  P. Harris,et al.  Research electronic data capture (REDCap) - A metadata-driven methodology and workflow process for providing translational research informatics support , 2009, J. Biomed. Informatics.

[15]  C. E..  WHO Coronavirus Disease (COVID-19) Dashboard , 2020 .